US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Claritev Corporation

38.13

-5.1300-11.86%

Post-market: 38.130.00000.00%16:10 EST

Volume:500.48K

Turnover:19.34M

Market Cap:630.12M

PE:-1.82

High:43.85

Open:42.37

Low:37.95

Close:43.26

52wk High:74.07

52wk Low:4.80

Shares:16.53M

Float Shares:5.58M

Volume Ratio:1.25

T/O Rate:8.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.9031

EPS(LYR):-101.9248

ROE:-646.34%

ROA:0.96%

PB:-6.19

PE(LYR):-0.37

Loading ...

Overview Company News Filings

Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance

Stock Track | Claritev Corporation Soars 11.59% on Strong Q3 Results and Raised 2025 Guidance

Earnings Flash (CTEV) Claritev Posts Q3 Loss $4.23, vs. FactSet Est of $3.59 Loss

MT Newswires Live

Claritev Q3 EPS $(4.23) Misses $(3.38) Estimate, Sales $245.959M Beat $235.806M Estimate

Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million

Claritev Corp - NOW Expects FY 2025 Capex $165 Mln to $175 Mln

THOMSON REUTERS

Claritev Corp - Q3 Revenues $246.0 Mln

THOMSON REUTERS

Claritev Corp - Q3 EPS $-4.23

THOMSON REUTERS

Claritev Corp - NOW Expects FY 2025 Revenue 2.8% to 3.2% From FY 2024

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Claritev Wins Deal to Provide Data and Analytics to Eastern Plains Healthcare Consortium

Claritev Invests in Klaim to Boost Healthcare Payment Solutions

Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and Mena Region

THOMSON REUTERS

Claritev upgraded to Buy from Neutral at Citi (yesterday)

Claritev Shares Rise After Upgrade From Citigroup

MT Newswires Live

The 5.9% return this week takes Claritev's (NYSE:CTEV) shareholders one-year gains to 432%

Simply Wall St.

Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target

MT Newswires Live

Claritev Raised to Buy From Neutral by Citigroup

Claritev Corp - on Oct 15, Renews Contracts With Its Ten Largest Clients - SEC Filing

THOMSON REUTERS

Press Release: Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTEV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":38.13,"timestamp":1763413200000,"preClose":43.26,"halted":0,"volume":500480,"hourTrading":{"tag":"盘后","latestPrice":38.13,"preClose":38.13,"latestTime":"16:10 EST","volume":883,"amount":33668.05,"timestamp":1763413827570},"delay":0,"floatShares":5577143,"shares":16525644,"eps":-20.903133,"marketStatus":"Closed","change":-5.13,"latestTime":"11-17 16:00:00 EST","open":42.37,"high":43.85,"low":37.95,"amount":19335309.7472,"amplitude":0.136385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.903133,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1763456400000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":43.26,"postHourTrading":{"tag":"盘后","latestPrice":38.13,"preClose":38.13,"latestTime":"16:10 EST","volume":883,"amount":33668.05,"timestamp":1763413827570},"volumeRatio":1.247833,"impliedVol":1.0021,"impliedVolPercentile":0.4451},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5577143,"roa":"0.96%","roe":"-646.34%","lyrEps":-101.92478,"volumeRatio":1.247833,"shares":16525644,"dividePrice":0,"high":43.85,"amplitude":0.136385,"preClose":43.26,"low":37.95,"week52Low":4.8,"pbRate":"-6.19","psRate":"0.66","week52High":74.0699,"institutionHeld":0,"latestPrice":38.13,"eps":-20.903133,"divideRate":0,"volume":500480,"delay":0,"ttmEps":-20.903133,"open":42.37,"prevYearClose":14.78,"prevWeekClose":43.26,"prevMonthClose":65.1,"prevQuarterClose":53.08,"fiveDayClose":57.84,"twentyDayClose":58.52,"sixtyDayClose":72.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32},{"market":"US","date":"2025-05-08","symbol":"CTEV","fiscalQuarterEnding":"2025/03","expectedEps":-2.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-3.43},{"market":"US","date":"2025-02-25","symbol":"CTEV","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-5.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761195600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2025-11-14","current":-1.855224,"percent":0.022346,"low":-3.349365,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"high":-0.170756,"avg":-0.87383,"sd":0.664146,"marketCap":730433464},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464}],"updateTime":1763400576621},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581884025","title":"Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581884025","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581884025?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:39","pubTimestamp":1762529940,"startTime":"0","endTime":"0","summary":"Claritev shares rose Friday after the company's third-quarter revenue exceeded expectations, leading to a raised full-year revenue outlook.Shares rose 12.8% to $69.87 in recent trading, and have risen fourfold year-to-date.The McLean, Va.-based healthcare technology company narrowed its third-quarter loss to $69.8 million, or $4.23 a share, from a loss of $391.5 million, or $24.25 a share, a year earlier. Analysts expected a loss of $3.59 a share.Revenue rose 6.7% to $246 million, beating Wall Street's estimate of $235.8 million.It now expects revenue to rise 2.8% to 3.2% for the year, compared with a prior view of up to 2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev Shares Up on Better-Than-Expected 3Q Revenue, Raised Guidance","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"1100239998","title":"Stock Track | Claritev Corporation Soars 11.59% on Strong Q3 Results and Raised 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1100239998","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100239998?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:32","pubTimestamp":1762525943,"startTime":"0","endTime":"0","summary":"Claritev Corporation (CTEV) saw its stock price soar by 11.59% in pre-market trading on Friday following the release of its third-quarter 2025 financial results and an upward revision of its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CTEV"],"gpt_icon":0},{"id":"2581009023","title":"Earnings Flash (CTEV) Claritev Posts Q3 Loss $4.23, vs. FactSet Est of $3.59 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009023","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009023?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:05","pubTimestamp":1762513535,"startTime":"0","endTime":"0","summary":"Earnings Flash (CTEV) Claritev Posts Q3 Loss $4.23, vs. FactSet Est of $3.59 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTEV"],"gpt_icon":0},{"id":"2581091580","title":"Claritev Q3 EPS $(4.23) Misses $(3.38) Estimate, Sales $245.959M Beat $235.806M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091580","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581091580?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:01","pubTimestamp":1762513317,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(4.23) per share which missed the analyst consensus estimate of $(3.38) by 25.15 percent. This is a 128.65 percent decrease over losses of $(1.85) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48714070/claritev-q3-eps-4-23-misses-3-38-estimate-sales-245-959m-beat-235-806m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2581091780","title":"Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091780","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581091780?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:01","pubTimestamp":1762513287,"startTime":"0","endTime":"0","summary":"Claritev Corporation reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL56VQjT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2581734009","title":"Claritev Corp - NOW Expects FY 2025 Capex $165 Mln to $175 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581734009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581734009?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA53BJLC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2581453009","title":"Claritev Corp - Q3 Revenues $246.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581453009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581453009?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA53BJLC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2581009755","title":"Claritev Corp - Q3 EPS $-4.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009755?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA53BJLC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2581009730","title":"Claritev Corp - NOW Expects FY 2025 Revenue 2.8% to 3.2% From FY 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009730?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA53BJLC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2581200968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2581200968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581200968?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:00","pubTimestamp":1762513200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Ares Cmm Rl Est                                 3Q      (.03)  6:00 AM. ·CNH Indus NV                                     3Q       .13   6:30 AM. ·Delek US Hldgs                                    3Q       .17   7:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATMU","ALXO","BODI","AKBA","BARK","ANIP","B","AQN","CEVA","AMBC","CTEV","DCGO","DCBO","BCSF","ASRT","BALY","ACRE","BAK","BW","BEKE","CLLS","CAMT","OSG","DDI","BEN","CGC","APEI","CHGG","CLMT","AXL","ADCT","AMCX","BKV","CNH","BLTE","DHX","CAPR","CEG","ANTA","CGEN","BAM","BDTX","BTDR","BXSL","AIRS","TASK","ARCT","BIP"],"gpt_icon":1},{"id":"2580212682","title":"Claritev Wins Deal to Provide Data and Analytics to Eastern Plains Healthcare Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2580212682","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580212682?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:44","pubTimestamp":1762209889,"startTime":"0","endTime":"0","summary":"Claritev Corporation has announced a strategic relationship with the Eastern Plains Healthcare Consortium , a group of 13 independent nonprofit rural hospitals in eastern Colorado. Through this agreement, Claritev will provide advanced provider data, analytics, and AI-driven services to help EPHC member hospitals improve financial sustainability, reduce administrative burdens, and identify new revenue and cost-saving opportunities. The initiative aims to enhance payment accuracy, provider benchmarking, and market analysis, enabling member hospitals and clinics to make more informed financial and clinical decisions. The collaboration is set to launch in the fourth quarter of 2025, with Claritev and EPHC working closely on implementation, integration, and ongoing support.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL3Jm8B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2578067673","title":"Claritev Invests in Klaim to Boost Healthcare Payment Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2578067673","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578067673?lang=en_us&edition=fundamental","pubTime":"2025-10-28 05:00","pubTimestamp":1761598836,"startTime":"0","endTime":"0","summary":"Claritev Corporation has announced a strategic equity investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The partnership aims to launch a co-branded Payment Acceleration Service, integrated within Claritev's provider network, to help healthcare organizations in the U.S. and MENA regions access reimbursements more quickly and predictably. This collaboration will combine Claritev's analytics and payor-provider infrastructure with Klaim's fintech expertise, offering providers near-instant liquidity on pending insurance claims and reducing payment cycles from the typical 30-120 days. The investment also supports Klaim's global restructuring and expansion plans.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nNDL8nn9hF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2578676219","title":"Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and Mena Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2578676219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578676219?lang=en_us&edition=fundamental","pubTime":"2025-10-28 05:00","pubTimestamp":1761598800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA5Z6FMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2577399842","title":"Claritev upgraded to Buy from Neutral at Citi (yesterday)","url":"https://stock-news.laohu8.com/highlight/detail?id=2577399842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577399842?lang=en_us&edition=fundamental","pubTime":"2025-10-22 23:20","pubTimestamp":1761146416,"startTime":"0","endTime":"0","summary":"Citi yesterday morning upgraded Claritev (CTEV) to Buy from Neutral with a price target of $74, up from $55. The firm has confidence in the company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-upgraded-to-buy-from-neutral-at-citi-yesterday-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-upgraded-to-buy-from-neutral-at-citi-yesterday-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2577806888","title":"Claritev Shares Rise After Upgrade From Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2577806888","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577806888?lang=en_us&edition=fundamental","pubTime":"2025-10-22 02:41","pubTimestamp":1761072096,"startTime":"0","endTime":"0","summary":"Claritev (CTEV) shares were up more than 12% in recent trading on Tuesday after Citigroup upgraded the healthcare technology firm's stock to buy from neutral.Trading volume stood at over 151,000 shares against a daily average of about 125,000.Price: 65.83, Change: +7.31, Percent Change: +12.48","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0162691827.USD","LU2456880835.USD","LU0310800965.SGD","LU0128525689.USD","BK4534","LU0980610538.SGD","BK4566","BK4504","LU0320765646.SGD","LU2360032135.SGD","LU2462157665.USD","BK4167","BK4559","LU1366192091.USD","LU2236285917.USD","LU0130102774.USD","BK4588","LU0098860793.USD","LU0648001328.SGD","LU1162221912.USD","LU1267930227.SGD","LU1244550221.USD","LU2125154935.USD","LU2125154778.USD","LU0170899867.USD","LU2417539215.USD","LU1668664300.SGD","IE00BSNM7G36.USD","LU0106831901.USD","LU0130517989.USD","LU1244550494.USD","LU1791807156.HKD","CTEV","BK4585","LU1244550577.SGD","LU0072461881.USD","BK4207","LU0477156953.USD","LU0052756011.USD","LU1201861249.SGD"],"gpt_icon":0},{"id":"2577803241","title":"The 5.9% return this week takes Claritev's (NYSE:CTEV) shareholders one-year gains to 432%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577803241","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577803241?lang=en_us&edition=fundamental","pubTime":"2025-10-22 01:28","pubTimestamp":1761067681,"startTime":"0","endTime":"0","summary":"While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ctev/claritev/news/the-59-return-this-week-takes-claritevs-nysectev-shareholder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ctev/claritev/news/the-59-return-this-week-takes-claritevs-nysectev-shareholder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4167","CTEV","NYSE"],"gpt_icon":0},{"id":"2577225828","title":"Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2577225828","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577225828?lang=en_us&edition=fundamental","pubTime":"2025-10-21 19:32","pubTimestamp":1761046367,"startTime":"0","endTime":"0","summary":"Claritev Corporation (CTEV) has an average rating of overweight and mean price target of $70.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2577821643","title":"Claritev Raised to Buy From Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2577821643","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577821643?lang=en_us&edition=fundamental","pubTime":"2025-10-21 18:56","pubTimestamp":1761044160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 21, 2025 06:56 ET (10:56 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2576775682","title":"Claritev Corp - on Oct 15,  Renews Contracts With Its Ten Largest Clients - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2576775682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576775682?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:46","pubTimestamp":1760647582,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nFWN3VX2T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2575106117","title":"Press Release: Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2575106117","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575106117?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:03","pubTimestamp":1760612580,"startTime":"0","endTime":"0","summary":"Claritev Corporation  , a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its third quarter 2025 financial results on Friday, November 7, 2025, and hold its conference call that morning at 8:00 am Eastern Time.Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose--built solutions that support all key players -- including payors, emplo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":80,"code":"91000000","status":"200"}]}}